Treatment burden and its impact on residual cardiovascular risk in community-dwelling older adults with cardiometabolic multimorbidity: an exploratory cross-sectional study
Over one-third of elderly CMM patients experience high treatment burden linked to inflammation-driven residual cardiovascular risk. Early treatment burden assessment and anti-inflammatory strategies may improve their prognosis in primary care.
Authors
- Ying Zhang (ORCID: https://orcid.org/0009-0006-1948-1854)
- Hua Jiang (ORCID: https://orcid.org/0009-0000-1807-3775)
- Yang Li (ORCID: https://orcid.org/0000-0002-0088-1544)
- Yang Gao
Institutions
- Tongji University (CN)
Publication Details
- Journal
- Postgraduate Medicine
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1080/00325481.2025.2510894
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China